Market Overview:
The global olanzapine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of mental disorders, increasing demand for olanzapine tablets and other medicine, and growing awareness about mental health. However, patent expiries of key players are likely to restrain the growth of the market during the forecast period. Based on type, the global olanzapine market is segmented into patent type and generics type. The patent type segment is further sub-segmented into immediate release (IR) and extended release (ER). The generics type segment is further sub-segmented into oral suspension/solution and tablets. Based on application, the global olanzapine market is divided into olanzapine tablets and other medicine. Other medicine includes drugs used for treating psychiatric disorders such as schizophrenia, bipolar disorder etc., which are not marketed under brand names but are available in generic form only.
Product Definition:
Olanzapine is a medication that is used to treat mental illnesses, such as bipolar disorder and schizophrenia. It can help to stabilize moods and decrease the symptoms of these disorders.
Patent Type:
Patent type is a legal protection that gives the owner of an invention the right to prevent others from making, using or selling the product until he files a patent application with the concerned authorities. The process of applying for patents is not very difficult and requires only one step such as filling an online form which can be accessed from any part of the world.
Generics Type:
Olanzapine, also known as zanypryl or zanaflex, is an atypical antipsychotic drug developed by Novartis AG. It was approved in the U.S and Europe in 2003 and 2004 respectively for the treatment of schizophrenia; it gained FDA approval for the treatment of bipolar disorder in 2008.
Application Insights:
Olanzapine tablets were the most prominent application of the global olanzapine market in 2017. The medicine is used for treating schizophrenia, bipolar disorder and other psychotic disorders. In addition, it is also used for the treatment of anxiety disorders such as obsessive-compulsive disorder (OCD) and social anxiety disorder. These applications are estimated to drive demand over the forecast period owing to increasing awareness about mental health issues coupled with growing availability of effective treatment options across regions.
Other medicines segment held a considerable share in 2017 due to high usage rates for various indications such as Parkinson¢â‚¬â„¢s disease psychosis and Alzheimer¢â‚¬â„¢s disease dementia among others.
Regional Analysis:
North America was the largest market for olanzapine with a revenue share of around 40% in 2017. The growth is majorly attributed to the high prevalence of schizophrenia and bipolar disorder in U.S. In 2015, it was estimated that 671,000 patients were suffering from schizophrenia while 1 million patients had been diagnosed with bipolar disorder (mania). These mental disorders create demand for treatment which eventually increases product demand over the forecast period.
Asia Pacific is expected to be one of the fastest growing regions owing to increasing awareness about mental health coupled with rising disposable income and improved healthcare facilities in emerging countries such as China and India will drive growth over next eight years.
Growth Factors:
- Increasing prevalence of mental disorders: The global prevalence of mental disorders is increasing at an alarming rate. According to the World Health Organization (WHO), around 450 million people suffer from some form of mental disorder. This number is expected to increase to 615 million by 2030. This growing population of patients with mental disorders is expected to drive the demand for olanzapine in the coming years.
- Rising awareness about olanzapine: There is a growing awareness among healthcare professionals and consumers about the benefits of olanzapine therapy for various psychiatric conditions. This is likely to boost demand for this drug in the coming years.
- Growing use of olanzapine in combination therapy: Olanzapine has been found to be effective when used in combination with other drugs for treating various psychiatric conditions such as bipolar disorder, schizophrenia, and major depressive disorder (MDD). This trend is likely to fuel growth prospects for the global olanzapine market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Olanzapine Market Research Report
By Type
Patent Type, Generics Type,
By Application
Olanzapine Tablets, Other Medicine,
By Companies
Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc., Mylan Pharmaceuticals, Par Pharmaceutical, Aurobindo Pharma, Torrent Pharmaceuticals, Jubilant Lifesciences, Sun Pharmaceutical, Sandoz, Hansoh Pharmaceutical, WATSON Pharmaceuticals(Changzhou), Zhejiang Langhua Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Olanzapine Market Report Segments:
The global Olanzapine market is segmented on the basis of:
Types
Patent Type, Generics Type,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Olanzapine Tablets, Other Medicine,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lilly
- Teva Pharmaceutical
- Dr. Reddy's Laboratories
- Apotex Inc.
- Mylan Pharmaceuticals
- Par Pharmaceutical
- Aurobindo Pharma
- Torrent Pharmaceuticals
- Jubilant Lifesciences
- Sun Pharmaceutical
- Sandoz
- Hansoh Pharmaceutical
- WATSON Pharmaceuticals(Changzhou)
- Zhejiang Langhua Pharmaceuticals
Highlights of The Olanzapine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Patent Type
- Generics Type
- By Application:
- Olanzapine Tablets
- Other Medicine
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Olanzapine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Olanzapine is an antipsychotic medication used to treat schizophrenia and other psychiatric disorders. It works by blocking the effects of dopamine and serotonin in the brain.
Some of the key players operating in the olanzapine market are Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc., Mylan Pharmaceuticals, Par Pharmaceutical, Aurobindo Pharma, Torrent Pharmaceuticals, Jubilant Lifesciences, Sun Pharmaceutical, Sandoz, Hansoh Pharmaceutical, WATSON Pharmaceuticals(Changzhou), Zhejiang Langhua Pharmaceuticals.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Olanzapine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Olanzapine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Olanzapine Market - Supply Chain
4.5. Global Olanzapine Market Forecast
4.5.1. Olanzapine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Olanzapine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Olanzapine Market Absolute $ Opportunity
5. Global Olanzapine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Olanzapine Market Size and Volume Forecast by Type
5.3.1. Patent Type
5.3.2. Generics Type
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Olanzapine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Olanzapine Market Size and Volume Forecast by Application
6.3.1. Olanzapine Tablets
6.3.2. Other Medicine
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Olanzapine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Olanzapine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Olanzapine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Olanzapine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Olanzapine Demand Share Forecast, 2019-2026
9. North America Olanzapine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Olanzapine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Olanzapine Market Size and Volume Forecast by Application
9.4.1. Olanzapine Tablets
9.4.2. Other Medicine
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Olanzapine Market Size and Volume Forecast by Type
9.7.1. Patent Type
9.7.2. Generics Type
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Olanzapine Demand Share Forecast, 2019-2026
10. Latin America Olanzapine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Olanzapine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Olanzapine Market Size and Volume Forecast by Application
10.4.1. Olanzapine Tablets
10.4.2. Other Medicine
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Olanzapine Market Size and Volume Forecast by Type
10.7.1. Patent Type
10.7.2. Generics Type
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Olanzapine Demand Share Forecast, 2019-2026
11. Europe Olanzapine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Olanzapine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Olanzapine Market Size and Volume Forecast by Application
11.4.1. Olanzapine Tablets
11.4.2. Other Medicine
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Olanzapine Market Size and Volume Forecast by Type
11.7.1. Patent Type
11.7.2. Generics Type
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Olanzapine Demand Share, 2019-2026
12. Asia Pacific Olanzapine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Olanzapine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Olanzapine Market Size and Volume Forecast by Application
12.4.1. Olanzapine Tablets
12.4.2. Other Medicine
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Olanzapine Market Size and Volume Forecast by Type
12.7.1. Patent Type
12.7.2. Generics Type
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Olanzapine Demand Share, 2019-2026
13. Middle East & Africa Olanzapine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Olanzapine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Olanzapine Market Size and Volume Forecast by Application
13.4.1. Olanzapine Tablets
13.4.2. Other Medicine
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Olanzapine Market Size and Volume Forecast by Type
13.7.1. Patent Type
13.7.2. Generics Type
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Olanzapine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Olanzapine Market: Market Share Analysis
14.2. Olanzapine Distributors and Customers
14.3. Olanzapine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Lilly
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teva Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Dr. Reddy's Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Apotex Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Mylan Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Par Pharmaceutical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Aurobindo Pharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Torrent Pharmaceuticals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Jubilant Lifesciences
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sun Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Sandoz
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Hansoh Pharmaceutical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. WATSON Pharmaceuticals(Changzhou)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Zhejiang Langhua Pharmaceuticals
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
